Versartis
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4200 Bohannon Dr Ste 250, Menlo Park, Ca...Phone Number
(650) 963-8580Website
www.versartis.comRevenue
$8.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Versartis
Versartis, Inc. is a biotechnology company developing therapeutic proteins for the treatment of endocrine disorders. The company was founded in December 2008 as a joint venture between Amunix Inc. and Index Ventures. The founders are Jeffrey Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger and Joshua Silverman. Versartis is developing new therapeutic proteins utilizing the novel half-life extension technology, XTEN. Versartis owns and develops the novel drug candidates that it has licensed from Amunix. Versartis is headquartered in Redwood City, California, USA. The company's lead program, VRS-317, has recently completed enrollment in a multi-center Phase 1 study in adult patients with growth hormone deficiency. The company is staffed with drug development experts and utilizes external contract services to execute on its product development plans in a capital-efficient manner.Explore more
Versartis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Versartis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Versartis launches new products
Congratulate Masked Content for being promoted to Masked Content at Versartis
Check if Versartis has recently received funding, and reach out quickly before it becomes old news!
Click to see if Versartis had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Versartis has new funding data
Versartis, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Versartis recently announced quarterly report
Check out if Versartis is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Versartis as Masked Content
Find more new buyers
Compare Similar Companies to Versartis
Compare insights from companies similar to Versartis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Versartis is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Versartis is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Versartis.
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Versartis
Sign Up For FreeTo access detailed company insights
Versartis, Inc. is a biotechnology company developing therapeutic proteins for the treatment of endocrine disorders. The company was founded in December 2008 as a joint venture between Amunix Inc. and Index Ventures. The founders are Jeffrey Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger and Joshua Silverman. Versartis is developing n... Read More
